Cargando…

The Beta-adrenergic agonist, Ractopamine, increases skeletal muscle expression of Asparagine Synthetase as part of an integrated stress response gene program

Synthetic beta-adrenergic agonists (BA) have broad biomedical and agricultural application for increasing lean body mass, yet a poor understanding of the biology underpinning these agents is limiting further drug discovery potential. Growing female pigs (77 ± 7 kg) were administered the BA, Ractopam...

Descripción completa

Detalles Bibliográficos
Autores principales: Brown, David, Ryan, Kevin, Daniel, Zoe, Mareko, Molebeledi, Talbot, Richard, Moreton, Joanna, Giles, Tom C. B., Emes, Richard, Hodgman, Charlie, Parr, Tim, Brameld, John M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6206132/
https://www.ncbi.nlm.nih.gov/pubmed/30374102
http://dx.doi.org/10.1038/s41598-018-34315-9
_version_ 1783366307970809856
author Brown, David
Ryan, Kevin
Daniel, Zoe
Mareko, Molebeledi
Talbot, Richard
Moreton, Joanna
Giles, Tom C. B.
Emes, Richard
Hodgman, Charlie
Parr, Tim
Brameld, John M.
author_facet Brown, David
Ryan, Kevin
Daniel, Zoe
Mareko, Molebeledi
Talbot, Richard
Moreton, Joanna
Giles, Tom C. B.
Emes, Richard
Hodgman, Charlie
Parr, Tim
Brameld, John M.
author_sort Brown, David
collection PubMed
description Synthetic beta-adrenergic agonists (BA) have broad biomedical and agricultural application for increasing lean body mass, yet a poor understanding of the biology underpinning these agents is limiting further drug discovery potential. Growing female pigs (77 ± 7 kg) were administered the BA, Ractopamine (20 ppm in feed), or the recombinant growth hormone (GH), Reporcin (10 mg/48 hrs injected) for 1, 3, 7, 13 (n = 10 per treatment, per time point) or 27 days (n = 15 per treatment). Using RNA-sequencing and inferred pathway analysis, we examined temporal changes to the Longissimus Dorsi skeletal muscle transcriptome (n = 3 per treatment, per time point) relative to a feed-only control cohort. Gene expression changes were affirmed by quantitative-PCR on all samples (n = 164). RNA-sequencing analysis revealed that BA treatment had greater effects than GH, and that asparagine synthetase (Asns) was the 5(th) most significantly increased gene by BA at day 3. ASNS protein expression was dramatically increased by BA treatment at day 7 (p < 0.05). The most significantly increased gene at day 3 was activating transcription factor 5 (Atf5), a transcription factor known to regulate ASNS gene expression. Gene and protein expression of Atf4, another known regulator of Asns expression, was not changed by BA treatment. Expression of more than 20 known Atf4 target genes were increased by BA treatment, suggesting that BA treatment induces an integrated stress response (ISR) in skeletal muscle of pigs. In support of this, mRNA expression of sestrin-2 (Sesn2) and cyclin-dependant kinase 1 alpha (Cdkn1a), two key stress-responsive genes and negative regulators of cellular growth, were also strongly increased from day 3 of BA treatment. Finally, tRNA charging was the most significantly enriched pathway induced by BA treatment, suggesting alterations to the translational capacity/efficiency of the muscle. BA-mediated changes to the skeletal muscle transcriptome are highly indicative of an integrated stress response (ISR), particularly genes relating to amino acid biosynthesis and protein translational capacity.
format Online
Article
Text
id pubmed-6206132
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-62061322018-11-01 The Beta-adrenergic agonist, Ractopamine, increases skeletal muscle expression of Asparagine Synthetase as part of an integrated stress response gene program Brown, David Ryan, Kevin Daniel, Zoe Mareko, Molebeledi Talbot, Richard Moreton, Joanna Giles, Tom C. B. Emes, Richard Hodgman, Charlie Parr, Tim Brameld, John M. Sci Rep Article Synthetic beta-adrenergic agonists (BA) have broad biomedical and agricultural application for increasing lean body mass, yet a poor understanding of the biology underpinning these agents is limiting further drug discovery potential. Growing female pigs (77 ± 7 kg) were administered the BA, Ractopamine (20 ppm in feed), or the recombinant growth hormone (GH), Reporcin (10 mg/48 hrs injected) for 1, 3, 7, 13 (n = 10 per treatment, per time point) or 27 days (n = 15 per treatment). Using RNA-sequencing and inferred pathway analysis, we examined temporal changes to the Longissimus Dorsi skeletal muscle transcriptome (n = 3 per treatment, per time point) relative to a feed-only control cohort. Gene expression changes were affirmed by quantitative-PCR on all samples (n = 164). RNA-sequencing analysis revealed that BA treatment had greater effects than GH, and that asparagine synthetase (Asns) was the 5(th) most significantly increased gene by BA at day 3. ASNS protein expression was dramatically increased by BA treatment at day 7 (p < 0.05). The most significantly increased gene at day 3 was activating transcription factor 5 (Atf5), a transcription factor known to regulate ASNS gene expression. Gene and protein expression of Atf4, another known regulator of Asns expression, was not changed by BA treatment. Expression of more than 20 known Atf4 target genes were increased by BA treatment, suggesting that BA treatment induces an integrated stress response (ISR) in skeletal muscle of pigs. In support of this, mRNA expression of sestrin-2 (Sesn2) and cyclin-dependant kinase 1 alpha (Cdkn1a), two key stress-responsive genes and negative regulators of cellular growth, were also strongly increased from day 3 of BA treatment. Finally, tRNA charging was the most significantly enriched pathway induced by BA treatment, suggesting alterations to the translational capacity/efficiency of the muscle. BA-mediated changes to the skeletal muscle transcriptome are highly indicative of an integrated stress response (ISR), particularly genes relating to amino acid biosynthesis and protein translational capacity. Nature Publishing Group UK 2018-10-29 /pmc/articles/PMC6206132/ /pubmed/30374102 http://dx.doi.org/10.1038/s41598-018-34315-9 Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Brown, David
Ryan, Kevin
Daniel, Zoe
Mareko, Molebeledi
Talbot, Richard
Moreton, Joanna
Giles, Tom C. B.
Emes, Richard
Hodgman, Charlie
Parr, Tim
Brameld, John M.
The Beta-adrenergic agonist, Ractopamine, increases skeletal muscle expression of Asparagine Synthetase as part of an integrated stress response gene program
title The Beta-adrenergic agonist, Ractopamine, increases skeletal muscle expression of Asparagine Synthetase as part of an integrated stress response gene program
title_full The Beta-adrenergic agonist, Ractopamine, increases skeletal muscle expression of Asparagine Synthetase as part of an integrated stress response gene program
title_fullStr The Beta-adrenergic agonist, Ractopamine, increases skeletal muscle expression of Asparagine Synthetase as part of an integrated stress response gene program
title_full_unstemmed The Beta-adrenergic agonist, Ractopamine, increases skeletal muscle expression of Asparagine Synthetase as part of an integrated stress response gene program
title_short The Beta-adrenergic agonist, Ractopamine, increases skeletal muscle expression of Asparagine Synthetase as part of an integrated stress response gene program
title_sort beta-adrenergic agonist, ractopamine, increases skeletal muscle expression of asparagine synthetase as part of an integrated stress response gene program
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6206132/
https://www.ncbi.nlm.nih.gov/pubmed/30374102
http://dx.doi.org/10.1038/s41598-018-34315-9
work_keys_str_mv AT browndavid thebetaadrenergicagonistractopamineincreasesskeletalmuscleexpressionofasparaginesynthetaseaspartofanintegratedstressresponsegeneprogram
AT ryankevin thebetaadrenergicagonistractopamineincreasesskeletalmuscleexpressionofasparaginesynthetaseaspartofanintegratedstressresponsegeneprogram
AT danielzoe thebetaadrenergicagonistractopamineincreasesskeletalmuscleexpressionofasparaginesynthetaseaspartofanintegratedstressresponsegeneprogram
AT marekomolebeledi thebetaadrenergicagonistractopamineincreasesskeletalmuscleexpressionofasparaginesynthetaseaspartofanintegratedstressresponsegeneprogram
AT talbotrichard thebetaadrenergicagonistractopamineincreasesskeletalmuscleexpressionofasparaginesynthetaseaspartofanintegratedstressresponsegeneprogram
AT moretonjoanna thebetaadrenergicagonistractopamineincreasesskeletalmuscleexpressionofasparaginesynthetaseaspartofanintegratedstressresponsegeneprogram
AT gilestomcb thebetaadrenergicagonistractopamineincreasesskeletalmuscleexpressionofasparaginesynthetaseaspartofanintegratedstressresponsegeneprogram
AT emesrichard thebetaadrenergicagonistractopamineincreasesskeletalmuscleexpressionofasparaginesynthetaseaspartofanintegratedstressresponsegeneprogram
AT hodgmancharlie thebetaadrenergicagonistractopamineincreasesskeletalmuscleexpressionofasparaginesynthetaseaspartofanintegratedstressresponsegeneprogram
AT parrtim thebetaadrenergicagonistractopamineincreasesskeletalmuscleexpressionofasparaginesynthetaseaspartofanintegratedstressresponsegeneprogram
AT brameldjohnm thebetaadrenergicagonistractopamineincreasesskeletalmuscleexpressionofasparaginesynthetaseaspartofanintegratedstressresponsegeneprogram
AT browndavid betaadrenergicagonistractopamineincreasesskeletalmuscleexpressionofasparaginesynthetaseaspartofanintegratedstressresponsegeneprogram
AT ryankevin betaadrenergicagonistractopamineincreasesskeletalmuscleexpressionofasparaginesynthetaseaspartofanintegratedstressresponsegeneprogram
AT danielzoe betaadrenergicagonistractopamineincreasesskeletalmuscleexpressionofasparaginesynthetaseaspartofanintegratedstressresponsegeneprogram
AT marekomolebeledi betaadrenergicagonistractopamineincreasesskeletalmuscleexpressionofasparaginesynthetaseaspartofanintegratedstressresponsegeneprogram
AT talbotrichard betaadrenergicagonistractopamineincreasesskeletalmuscleexpressionofasparaginesynthetaseaspartofanintegratedstressresponsegeneprogram
AT moretonjoanna betaadrenergicagonistractopamineincreasesskeletalmuscleexpressionofasparaginesynthetaseaspartofanintegratedstressresponsegeneprogram
AT gilestomcb betaadrenergicagonistractopamineincreasesskeletalmuscleexpressionofasparaginesynthetaseaspartofanintegratedstressresponsegeneprogram
AT emesrichard betaadrenergicagonistractopamineincreasesskeletalmuscleexpressionofasparaginesynthetaseaspartofanintegratedstressresponsegeneprogram
AT hodgmancharlie betaadrenergicagonistractopamineincreasesskeletalmuscleexpressionofasparaginesynthetaseaspartofanintegratedstressresponsegeneprogram
AT parrtim betaadrenergicagonistractopamineincreasesskeletalmuscleexpressionofasparaginesynthetaseaspartofanintegratedstressresponsegeneprogram
AT brameldjohnm betaadrenergicagonistractopamineincreasesskeletalmuscleexpressionofasparaginesynthetaseaspartofanintegratedstressresponsegeneprogram